Clinical Trial Update: Multicenter Double-Blind Randomized Split-Face Study to Evaluate Revanesse® Ultra vs Restylane® for Correction of NLF [NA]

View source ↗

Summary

A completed multicenter, double-blind randomized trial comparing Revanesse Ultra to Restylane for nasolabial fold correction; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolabial Fold Correction

Drugs mentioned

• Restylane (hyaluronic acid dermal filler)
• Revanesse Ultra+

Snippet

Sponsor: Prollenium Medical Technologies Inc. | Conditions: Nasolabial Fold Correction | NA | Status: COMPLETED | Results posted: 2017-12-13